Enhancement of muscle blood cell flux and pO2 by cromakalim (BRL 34915) and other compounds enhancing membrane K+ conductance, but not by Ca2+ antagonists or hydralazine, in an animal model of occlusive arterial disease

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  1988-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00168848PMID 3393236
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vasodilator drugs for peripheral vascular disease.

  2010cited by this paper
• Investigation of the influence of acetylcholine on the distribution of capillary flow in the skeletal muscle of the guinea pig by recording of thepO2 in the muscle tissue

  2004cited by this paper
• The effect of short-term and long-term femoral artery ligation on rat calf muscle oxygen tension, blood flow, metabolism and function.

  1988cited by this paper
• Nicorandil-induced changes in the distribution of cardiac output and coronary blood flow in pigs

  1987cited by this paper
• Evidence that the mechanism of the inhibitory action of pinacidil in rat and guinea‐pig smooth muscle differs from that of glyceryl trinitrate

  1987cited by this paper
• Effect of the K+ efflux stimulating vasodilator BRL 34915 on 86Rb+ efflux and spontaneous activity in guinea‐pig portal vein

  1987cited by this paper
• Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein

  1986cited by this paper
• The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels

  1986cited by this paper
• BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models.

  1986cited by this paper
• The effect of acute and chronic femoral artery ligation on the blood flow through the gastrocnemius muscle of the rat examined using laser Doppler flowmetry and xenon-133 clearance.

  1985cited by this paper
• Skeletal Muscle Microcirculation and Changes in Transmural and Perfusion Pressure

  1984cited by this paper
• Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model.

  1984cited by this paper
• Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.

  1984cited by this paper
• Effects of 2-nicotinamidoethyl nitrate (nicorandil; SG-75) and its derivative on smooth muscle cells of the canine mesenteric artery.

  1984cited by this paper
• Comparative Effects of a New Nicotinamide Nitrate Derivative, Nicorandil (SG 75), with Nifedipine and Nitroglycerin on True Collateral Blood Flow Following an Acute Coronary Occlusion in Dogs

  1984cited by this paper
• The Acute Effects of Nifedipine on Calf and Forefoot Blood Flow in Patients with Peripheral Arterial Insufficiency

  1983cited by this paper
• Vasodilators: minoxidil and drugs used in peripheral vascular and cerebral disorders.

  1983cited by this paper
• Calcium antagonist and the peripheral circulation: differences and similarities between PY 108–068, nicardipine, verapamil and diltiazem

  1983cited by this paper
• Vascular effects in dogs of pinacidil (P 1134), a novel vasoactive antihypertensive agent.

  1983cited by this paper
• Effects of PY 108–068, a New Calcium Antagonist, on General Hemodynamics and Regional Blood Flow in Anesthetized Cats: A Comparison with Nifedipine

  1982cited by this paper
• The hypotensive mechanisms of the new anti-anginal drug, N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) in beagle dogs.

  1981cited by this paper
• Regional blood flow and cardiac responses to hydralazine.

  1980cited by this paper
• Muscle blood flow disturbances produced by simultaneously elevated venous and total muscle tissue pressure.

  1980cited by this paper
• A New Instrument for Continuous Measurement of Tissue Blood Flow by Light Beating Spectroscopy

  1980cited by this paper
• Vasodilator drugs for peripheral vascular disease.

  1979cited by this paper
• Drug therapy: vasodilator drugs in peripheral vascular disease.

  1979cited by this paper
• Po2 and microflow histograms of the beating heart in response to changes in arterial Po2

  1978cited by this paper
• Effects of diltiazem hydrochloride (CRD-401) on hepatic, superior mesenteric and femoral hemodynamics.

  1978cited by this paper
• Role of oxygen in arteriolar functional vasodilation in hamster striated muscle.

  1978cited by this paper
• Behavior of microflow and local PO2 of the brain cortex during and after direct electrical stimulation. A contribution to the problem of metabolic regulation of microcirculation in the brain.

  1976cited by this paper
• Behavior of microflow and localPO2 of the brain cortex during and after direct electrical stimulation

  1976cited by this paper
• Reactive Hyperemia in Arterioles and Capillaries of Frog Skeletal Muscle following Microocclusion

  1972cited by this paper
• Low flow states in the microvessels of skeletal muscle in cat.

  1972cited by this paper
• [Pharmacology of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine, a new peripheral vasodilator agent].

  1971cited by this paper
• Ineffectiveness of isoxsuprine on intermittent claudication.

  1970cited by this paper
• Effect of vasodilator drugs in vasoconstricted normal subjects.

  1968cited by this paper
• Effect of vasodilator drugs in vasoconstricted normal subjects.

  1968cited by this paper
• An Evaluation of Vasodilator Drugs in Occlusive Vascular Disease By Measurement

  1966cited by this paper
• NEW INSTRUMENT.

  1964cited by this paper
• Haemodynamic studies on experimental obstruction of the femoral artery in the cat with special reference to the peripheral action of vasoactive substances.

  1962cited by this paper

• Activation of ATP-sensitive K-channel promotes the anticonvulsant properties of cannabinoid receptor agonist through mitochondrial ATP level reduction.

  2019cites this paper
• Opening of the Adenosine Triphosphate-sensitive Potassium Channel Attenuates Morphine Tolerance by Inhibiting JNK and Astrocyte Activation in the Spinal Cord

  2016cites this paper
• Is there a therapeutic future for ‘ potassium channel openers ’ ?

  2012cites this paper
• channel therapeutics at the bedside

  2009cites this paper
• Focused issue on KATP channels K ATP channel therapeutics at the bedside

  2005cites this paper
• K(ATP) channel therapeutics at the bedside.

  2005cites this paper
• Smooth muscle K+ channel openers; their pharmacology and clinical potential

  2004cites this paper
• Cardiovascular Profile of a Novel Potassium Channel Opener, KRN4884

  1998cites this paper
• Protective effect of the K+ channel opener KRN4884 on peripheral occlusive arterial disease in rats.

  1998cites this paper
• Collateral response to activation of potassium channels in vivo

  1998cites this paper
• Muscle contraction-induced steal model in the anesthetized cat.

  1998cites this paper
• ATP-sensitive and inwardly rectifying potassium channels in smooth muscle.

  1997cites this paper
• Response of coronary microvascular collaterals to activation of ATP-sensitive K+ channels.

  1997cites this paper
• Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.

  1996cites this paper
• Experimental models of chronic lower extremity arterial occlusive disease: lessons for drug development.

  1996cites this paper
• Potassium channel activation: a potential therapeutic approach?

  1996cites this paper
• Is there a therapeutic future for "potassium channel openers'?

  1996cites this paper
• Modulation of vasodilatation to levcromakalim by adenosine analogues in the rabbit ear: an explanation for hypoxic augmentation

  1994cites this paper
• Effect of cromakalim on skeletal muscle function and blood flow in the ferret ischemic hindlimb.

  1994cites this paper
• POTASSIUM CHANNEL OPENERS AND OTHER REGULATORS OF KATP CHANNELS

  1994cites this paper
• Intracellular acidification and ADP enhance nicorandil induction of ATP sensitive potassium channel current in cardiomyocytes.

  1994cites this paper
• [Potassium agonists: mechanisms of action and therapeutic expectations].

  1993cites this paper
• ATP-sensitive potassium channels and skeletal muscle function in vitro.

  1993cites this paper
• Modulation of vasodilatation to levcromakalim by hypoxia and EDRF in the rabbit isolated ear: a comparison with pinacidil, sodium nitroprusside and verapamil

  1993cites this paper
• Current trends in the study of potassium channel openers.

  1993cites this paper
• Physiological mechanisms and pharmacological regulation of acute collateral perfusion.

  1993cites this paper
• Therapeutic potential of potassium channel openers in peripheral vascular disease and asthma

  1993cites this paper
• The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers

  1992cites this paper
• Potassium Channel Openers: Pharmacology and Therapeutic Prospects

  1992cites this paper
• Recent progress in potassium channel opener pharmacology.

  1992cites this paper
• Preferential small arteriolar vasodilatation by the potassium channel opener, BRL 38227, in conscious spontaneously hypertensive rats.

  1992cites this paper
• Potassium channel openers: pharmacological and clinical aspects

  1992cites this paper
• Effects of BRL 38227, sodium nitroprusside and verapamil on collateral perfusion following acute arterial occlusion in the rabbit isolated ear

  1992cites this paper
• Clinical pharmacology of potassium channel openers.

  1992cites this paper
• Potassium channel activator drugs: Mechanism of action, pharmacological properties, and therapeutic potential

  1992cites this paper
• A K+ channel opener in vascular smooth muscle: pharmacology and mechanism of action of cromakalim

  1991cites this paper
• Spasmolytic effect of cromakalim in dog coronary artery in vitro

  1991cites this paper
• Reactivity of canine isolated epicardial collateral coronary arteries. Relation to vessel structure.

  1991cites this paper
• New developments in cardiovascular magnetic resonance imaging and spectroscopy.

  1991cites this paper
• The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs

  1990cites this paper
• Effects of cromakalim, RP49356, diazoxide, glibenclamide and galanin in rat portal vein.

  1990cites this paper
• Antihypertensive Agents Which Open Smooth Muscle K Channels

  1990cites this paper
• Potassium channel openers. Pharmacological effects and future uses.

  1990cites this paper
• Clinical Studies with the Potassium Channel Activator Cromakalim in Normotensive and Hypertensive Subjects

  1990cites this paper
• Potassium Channel Openers

  1990cites this paper
• Potassium channel openers and vascular smooth muscle relaxation.

  1990cites this paper
• Moving together: K+ channel openers and ATP-sensitive K+ channels.

  1989cites this paper